# hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

> **NCT06853522** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** exosomes derived from human umbilical cord mesenchymal stem cells
- **DRUG:** saline +5% albumin

## Key facts

- **NCT ID:** NCT06853522
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2027-04-04
- **Final completion:** 2028-04-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06853522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06853522, "hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06853522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*